A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DAT / DA transporter

[Related PubMed/MEDLINE]
Total Number of Papers: 222
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DAT  (>> Co-occurring Abbreviation)
Long Form:   DA transporter
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 G protein betagamma subunits play a critical role in the actions of amphetamine. DA, NAc
2019 NMDA receptor deletion on dopamine neurons disrupts visual discrimination and reversal learning. DA, NMDA
2019 Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention. ADHD, D3R, DA, NE, NET, PFC
2019 Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. ADHD, CPP, DA
2019 Task-Dependent Differences in Operant Behaviors of Rats With Acute Exposure to High Ambient Temperature: A Potential Role of Hippocampal Dopamine Reuptake Transporters. BDNF, DA, dHip, DRL 10-s, FR1, IRT, Ta
2018 Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. APZ, AUD, COMT, DA, VNTR, VS
2018 Effects of taurine on striatal dopamine transporter expression and dopamine uptake in SHR rats. ADHD, BDNF
2018 ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors. DA, LUHMES, NRG1
2018 Frontostriatal and Dopamine Markers of Individual Differences in Reinforcement Learning: A Multi-modal Investigation. DA, RL
10  2018 Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure. DA
11  2018 Neonatal programming with testosterone propionate reduces dopamine transporter expression in nucleus accumbens and methylphenidate-induced locomotor activity in adult female rats. DA, EV, NAcc, TP
12  2018 Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559. ADE, ADE, ADHD, D2AR, D2ARs, DA, DS, TH, VS
13  2018 Regional differences in dopamine release in the R6/2 mouse caudate putamen. DA, HD
14  2018 Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions. DA
15  2017 Altered Dopamine Synaptic Markers in Postmortem Brain of Obese Subjects. BMI, DA, NAc, SN, TH
16  2017 Decreased lymphocyte dopamine transporter in romantic lovers. DA
17  2017 Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. BDNF, DA, GFAP, MPTP, VMAT2
18  2017 Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain. DA, LC, NAc, NE, NET, VTA
19  2017 Reduced levels of Cacna1c attenuate mesolimbic dopamine system function. LTCC, MLDA, NAc, VTA
20  2017 Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. CPu, DA, HPLC, MPH, phMRI
21  2017 Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization. DA, ER, GFP, hDAT, Swip
22  2017 Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study. DA
23  2017 The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism. DA, Swip
24  2016 Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity. D2R, DA, dSTR, RNAi, SN
25  2016 Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men. DA
26  2016 Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence. DA
27  2016 DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine. DA
28  2016 Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans. DA
29  2016 Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry. DA, FSCV
30  2016 Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. 2-AG, AA, DA, gamma-KA, GLP-1, LS
31  2016 Individual differences in impulsive action and dopamine transporter function in rat orbitofrontal cortex. DA, mPFC
32  2016 Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function. AMPH, DA, NAc
33  2016 Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. DA, hDAT, WT hDAT
34  2016 Optogenetic activation of dopamine neurons in the ventral tegmental area induces reanimation from general anesthesia. CSSGA, DA, FLEX, VTA
35  2016 Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in invivo imaging studies. DA, L-DOPA
36  2016 PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux. DA, SA
37  2016 Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. DA, DHA, MPTP, PD, VMAT2
38  2016 Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal. DA, NAc, TH, VTA
39  2015 Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking. DA, IntA
40  2015 Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane. DA
41  2015 Dissociable roles of dopamine and serotonin transporter function in a rat model of negative urgency. DA, mPFC, NAc, OFC, STR
42  2015 Dual regulating effect of Ningdong granule on extracellular dopamine content of two kinds of Tourette's syndrome rat models. APO, HAL, HPLC, IDPN, NDG, TCM, TS
43  2015 Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats. DA, ICSS, NAc
44  2015 Glutamate Receptors within the Mesolimbic Dopamine System Mediate Alcohol Relapse Behavior. DA
45  2015 Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress. DA, mPFC, NET, PFC
46  2015 Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. DA, hDAT, Tat
47  2015 Neonatal exposure to amphetamine alters social affiliation and central dopamine activity in adult male prairie voles. AMPH, DA, TH, VTA
48  2015 Ni(2+) affects dopamine uptake which limits suitability as inhibitor of T-type voltage-gated Ca(2+) channels. DA
49  2015 Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. DA, VMAT
50  2015 The 5alpha-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. DA, DHT, MPTP, PD, TH, VMAT2
51  2014 Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene. DAergic, DISC1, GABA, METH, NAc, PV
52  2014 Association between amygdala reactivity and a dopamine transporter gene polymorphism. DA
53  2014 Dopamine in human follicular fluid is associated with cellular uptake and metabolism-dependent generation of reactive oxygen species in granulosa cells: implications for physiology and pathology. DA, GCs, IVF, PCOS, ROS
54  2014 Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine. DA
55  2014 Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. ADHD, DA
56  2014 Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. DA
57  2014 Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. BD, DA, FRET, TH
58  2014 Positive and negative feedback learning and associated dopamine and serotonin transporter binding after methamphetamine. DA, mAMPH
59  2014 Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum. ADHD, DS, EAA, IN-DA, L-Asp, L-Glu, MES, NHE, NRB, PFC, TH, VTA
60  2014 Running wheel exercise before a binge regimen of methamphetamine does not protect against striatal dopaminergic damage. DA, mAMPH
61  2014 Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. A2AR, D1R, D2R, DA, GRK
62  2014 Striatal astrocytes act as a reservoir for L-DOPA. DA, PD
63  2014 The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI. DA, PET, TBI
64  2013 Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. 5-HTT, DA, GABA, HI, LI, NAcb, NAcbC
65  2013 High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. 5-HIAA, DA, FR and PR, METH, SERT, TSPO
66  2013 Impulse-dependent extracellular resting dopamine concentration in rat striatum in vivo. DA
67  2013 Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine. DA, nAChR, SERT
68  2013 Locomotor hyperactivity in 14-3-3zeta KO mice is associated with dopamine transporter dysfunction. DA, KO, TH
69  2013 Monoaminergic dysfunction in recreational users of dexamphetamine. CBF, DA, dAMPH, MPH, NA, phMRI, SPECT
70  2013 Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. DA, hDAT
71  2013 Novel aspects of striatal plasticity associated with long-term levo-dopa administration. DA, TH
72  2013 Pre-gestational stress alters stress-response of pubertal offspring rat in sexually dimorphic and hemispherically asymmetric manner. COMT, CUS, DA, DOPAC, mPFC, NET
73  2012 Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. ADHD, AMPH, DA, PKC
74  2012 CNS dopamine transmission mediated by noradrenergic innervation. D1R, DA, LC, NE, TH, VTA
75  2012 Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors. DA, NAcc, TH, VTA, WT
76  2012 Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. AMPH, DA, NAc, NE, NET, PLC, pMeCP2
77  2012 Dopamine mediates cocaine-induced conditioned taste aversions as demonstrated with cross-drug preexposure to GBR 12909. CTA, DA
78  2012 Effect of a chronic treatment with 17beta-estradiol on striatal dopamine neurotransmission and the Akt/GSK3 signaling pathway in the brain of ovariectomized monkeys. ---
79  2012 Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. DA, VTA
80  2012 Nicotine dynamically modulates dopamine clearance in rat striatum in vivo. DA, MFB
81  2012 Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease. DA, GSK-3, MPTP, PD, VMAT2, WT
82  2012 Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine. DA, DOPAC, METH, SFN
83  2012 Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells. aSyn, DA, DAergic, FACS, Nurr1, PD, PI, VMAT2
84  2012 Restriction of neural precursor ability to respond to Nurr1 by early regional specification. CNS, CTX, DA, GE, MB, NPs, SC, SVZ, TH
85  2012 Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters. 5-HT, DA
86  2012 The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor. DA, FAE, NE, NET, SERT
87  2011 Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. DA, METH, MT, Nrf2
88  2011 Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats. D-AMPH, DA, RHS
89  2011 Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. DA
90  2011 Dopamine-related drugs act presynaptically to potentiate GABA(A) receptor currents in VTA dopamine neurons. DA, eIPSCs, GABA, mIPSCs, NO, VTA
91  2011 Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. BDNF, DA, VMAT2, WT
92  2011 Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters. MDMA, PFC
93  2011 Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. DA, Flot1, NTTs, PKC
94  2011 Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. AMPH, DA, HF
95  2011 meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. DA, MTD, SERT, VMAT2
96  2011 Mimicking synaptic effects of addictive drugs with selective dopamine neuron stimulation. AMPAR, DA, VTA
97  2011 Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET). DA, PET, SPECT
98  2011 Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. DA, H3Ac, NPCs, TH, VM, VM-NPCs
99  2011 Redistribution of DAT/alpha-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease. DA, PD
100  2011 Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. DA, mPFC, NAc, NE, NET